[HTML][HTML] Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer

X Han, W Chang, X Xia - Frontiers in Oncology, 2022 - frontiersin.org
Cervical cancer (CC) poses a serious threat to women's health. Although many early-stage
patients have a good prognosis, there are still a lack of effective therapies for advanced and …

Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer

L Liu, J Liu, Q Lyu, J Huang, Y Chen, C Feng, Y Liu… - Scientific reports, 2023 - nature.com
Disulfidptosis is a newly discovered form of cell death. Not yet clearly classified as
programmed cell death or accidental cell death. This study aimed to create a novel …

Current Update on PET/MRI in Gynecological Malignancies—A Review of the Literature

M Virarkar, SS Vulasala, L Calimano-Ramirez… - Current …, 2023 - mdpi.com
Early detection of gynecological malignancies is vital for patient management and
prolonging the patient's survival. Molecular imaging, such as positron emission tomography …

Circular RNA circACAP2 Suppresses Ferroptosis of Cervical Cancer during Malignant Progression by miR‐193a‐5p/GPX4

Y Liu, L Li, Z Yang, D Wen, Z Hu - Journal of oncology, 2022 - Wiley Online Library
Cervical cancer is among the most cancer types, with an extremely high global incidence
and mortality. Ferroptosis is a newly reported programmed cell death process that differs …

Long non‑coding RNA USP30‑AS1 aggravates the malignant progression of cervical cancer by sequestering microRNA‑299‑3p and thereby overexpressing PTP4A1

M Chen, Y Chi, H Chen, L Zhao - Oncology Letters, 2021 - spandidos-publications.com
Abstract USP30 antisense RNA 1 (USP30‑AS1) has been studied in bladder urothelial
carcinoma. However, the detailed role of USP30‑AS1 in cervical cancer remains to be …

[HTML][HTML] m6A regulator-mediated tumour infiltration and methylation modification in cervical cancer microenvironment

W Zhang, P Xiao, J Tang, R Wang, X Wang… - Frontiers in …, 2022 - frontiersin.org
Background N6-methyladenosine (m6A) is the most abundant internal mRNA modification in
eukaryotic cells. There is accumulating evidence that m6A methylation can play a significant …

Preliminary MRI study of extracellular volume fraction for identification of lymphovascular space invasion of cervical cancer

W Wang, X Fan, J Yang, X Wang, Y Gu… - Journal of Magnetic …, 2023 - Wiley Online Library
Background Lymphovascular space invasion (LVSI) is a risk factor for poor prognosis of
cervical cancer. Preoperative identification of LVSI is very difficult. Purpose To evaluate the …

[HTML][HTML] Cervical cancer

JR Fowler, EV Maani, CJ Dunton, DP Gasalberti… - 2017 - europepmc.org
Cervical Cancer - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe
PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech …

MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or …

G Wei, P Jiang, Z Tang, A Qu, X Deng, F Guo… - Magnetic Resonance …, 2022 - Elsevier
Objectives To build radiomics based OS prediction tools for local advanced cervical cancer
(LACC) patients treated by concurrent chemoradiotherapy (CCRT) alone or followed by …

Mucin-16 targeted mesoporous nano-system for evaluation of cervical cancer via dual-modal computed tomography and ultrasonography

A Tarighatnia, MH Abdkarimi, ND Nader… - New journal of …, 2021 - pubs.rsc.org
Mesoporous silica-coated bismuth nanoparticles (NPs) are dual-modal contrast agents that
enable detection and quantification of cervical cancers at early stages using computed …